LYEL – lyell immunopharma, inc. (US:NASDAQ)

News

DELFI Diagnostics Appoints Charles Newton to Board of Directors [Yahoo! Finance]
Lyell Immunopharma (LYEL) was upgraded by Wall Street Zen from "sell"
Lyell Immunopharma, Inc. (LYEL) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript [Seeking Alpha]
A First Look At Lyell Immunopharma [Seeking Alpha]
Lyell Immunopharma (LYEL) is now covered by Needham & Company LLC. They set a "buy" rating and a $44.00 price target on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com